rxstat › Shortages › Lansoprazole

Lansoprazole shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Some Lansoprazole products are in shortage in Canada (6 of 22 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Dec 29, 2026.
Products affected
6 / 22
In shortage since
Sep 3, 2024
Est. full return
Dec 29, 2026
Reports on file
123
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.

Reports by product

Active shortage
APO-LANSOPRAZOLE
15MG · CAPSULE (DELAYED RELEASE) · APOTEX INC
DIN 02293811 · since Jun 30, 2026, est. end Jul 17, 2026 · Disruption of the manufacture of the drug.
Active shortage
MYLAN-LANSOPRAZOLE
30MG · CAPSULE (DELAYED RELEASE) · MYLAN PHARMACEUTICALS ULC
DIN 02353849 · since Jun 11, 2026, est. end Dec 29, 2026 · Disruption of the manufacture of the drug.
Active shortage
MYLAN-LANSOPRAZOLE
15MG · CAPSULE (DELAYED RELEASE) · MYLAN PHARMACEUTICALS ULC
DIN 02353830 · since Mar 23, 2026, est. end Dec 29, 2026 · Disruption of the manufacture of the drug.
Active shortage
APO-LANSOPRAZOLE
15MG · CAPSULE (DELAYED RELEASE) · APOTEX INC
DIN 02293811 · since Dec 16, 2025, est. end Jan 30, 2026 · Disruption of the manufacture of the drug.
Active shortage
M-LANSOPRAZOLE
15MG · CAPSULE (DELAYED RELEASE) · MANTRA PHARMA INC
DIN 02489805 · since Nov 11, 2024, no end estimate · Delay in shipping of the drug.
Active shortage
M-LANSOPRAZOLE
30MG · CAPSULE (DELAYED RELEASE) · MANTRA PHARMA INC
DIN 02489813 · since Sep 3, 2024, no end estimate · Delay in shipping of the drug.
Active shortage
RIVA-LANSOPRAZOLE
30MG · CAPSULE (DELAYED RELEASE) · LABORATOIRE RIVA INC.
DIN 02422816 · since Apr 30, 2025, no end estimate · Delay in shipping of the drug.
Anticipated
LANSOPRAZOLE
15MG · CAPSULE (DELAYED RELEASE) · SANIS HEALTH INC
DIN 02357682 · Disruption of the manufacture of the drug.
Resolved
APO-LANSOPRAZOLE
15MG · CAPSULE (DELAYED RELEASE) · APOTEX INC
DIN 02293811 · ended Mar 26, 2026 · Disruption of the manufacture of the drug.
Resolved
SANDOZ LANSOPRAZOLE
30MG · CAPSULE (DELAYED RELEASE) · SANDOZ CANADA INCORPORATED
DIN 02385651 · ended Feb 16, 2026 · Disruption of the manufacture of the drug.
Resolved
SANDOZ LANSOPRAZOLE
15MG · CAPSULE (DELAYED RELEASE) · SANDOZ CANADA INCORPORATED
DIN 02385643 · ended Feb 16, 2026 · Disruption of the manufacture of the drug.
Resolved
APO-LANSOPRAZOLE
30MG · CAPSULE (DELAYED RELEASE) · APOTEX INC
DIN 02293838 · ended Feb 12, 2026 · Disruption of the manufacture of the drug.

Showing 12 of 60 reports. All reports are on file with Health Canada.

What's happening

Lansoprazole is currently affected by 6 active shortage reports filed with Health Canada by APOTEX INC, MYLAN PHARMACEUTICALS ULC, MANTRA PHARMA INC, LABORATOIRE RIVA INC..

The reported causes are: disruption of the manufacture of the drug; delay in shipping of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Lansoprazole is classified under “DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)” (ATC A02BC).

Recent changes

Common questions

When will Lansoprazole be back in stock in Canada?

The latest manufacturer estimate is Dec 29, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.

Why is Lansoprazole in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (drugs for peptic ulcer and gastroesophageal reflux disease (gerd))

Widespread shortageFamotidine3 of 13 reported products affected · est. return Sep 18, 2026Partial shortageCimetidine3 of 9 reported products affectedPartial shortageEsomeprazole12 of 26 reported products affected · est. return Oct 10, 2027Partial shortageOmeprazole10 of 22 reported products affected · est. return Aug 14, 2026Partial shortagePantoprazole7 of 35 reported products affected · est. return Sep 29, 2026Partial shortageRabeprazole4 of 21 reported products affected · est. return Jun 30, 2026

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.